{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:57:19Z","timestamp":1767135439427,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd013827","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000}}],"reference-count":72,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013827.pub2","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T07:34:23Z","timestamp":1701329663000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Progestogens for prevention of luteinising hormone (LH) surge in women undergoing controlled ovarian hyperstimulation as part of an assisted reproductive technology (ART) cycle"],"prefix":"10.1002","volume":"2023","author":[{"given":"Demi\u00e1n","family":"Glujovsky","sequence":"additional","affiliation":[{"name":"Reproductive Medicine; CEGYR (Centro de Estudios en Gen\u00e9tica y Reproducci\u00f3n); Buenos Aires Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romina","family":"Pesce","sequence":"additional","affiliation":[{"name":"Reproductive Medicine; Hospital Italiano de Buenos Aires; Buenos Aires Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Miguens","sequence":"additional","affiliation":[{"name":"Reproductive Medicine; CEGYR (Centro de Estudios en Gen\u00e9tica y Reproducci\u00f3n); Buenos Aires Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Sueldo","sequence":"additional","affiliation":[{"name":"Reproductive Medicine; CEGYR (Centro de Estudios en Ginecologia y Reproducci\u00f3n); Buenos Aires Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agust\u00edn","family":"Ciapponi","sequence":"additional","affiliation":[{"name":"Argentine Cochrane Centre; Instituto de Efectividad Cl\u00ednica y Sanitaria (IECS-CONICET); Buenos Aires Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2023,11,30]]},"reference":[{"key":"10.1002\/14651858.CD013827.pub2-BIB0001|cit1","unstructured":"Begueria R Garcia D Vassena R Rodriguez A Medroxyprogesterone acetate versus ganirelix in oocyte donation cycles stimulated using GnRH antagonist protocol triggered with GnRH agonist: a randomized controlled trial (RCT) Human Reproduction 2018 i108"},{"issue":"5","key":"10.1002\/14651858.CD013827.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/humrep\/dez034","article-title":"Medroxyprogesterone acetate versus ganirelix in oocyte donation: a randomized controlled trial","volume":"34","author":"Begueria","year":"2019","journal-title":"Human Reproduction"},{"issue":"3","key":"10.1002\/14651858.CD013827.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1016\/j.fertnstert.2020.08.636","article-title":"The use of dydrogesterone to prevent lh peak in random-start ovarian stimulation for fertility preservation","volume":"114","author":"Braham","year":"2020","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD013827.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1016\/j.fertnstert.2019.07.628","article-title":"Dydrogesterone for prevent LH surge yields similar outcomes to ganirelix in a shared oocyte donor cycle with subsequent frozen-thawed embryo transfer: comparison of donors and recipients","volume":"112 Suppl","author":"Cambiaghi","year":"2019","journal-title":"Fertility and Sterility. Conference: 75th Scientific Congress of the American Society for Reproductive Medicine, October 12-16, 2019, Philadelphia, Pennsylania"},{"key":"10.1002\/14651858.CD013827.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fendo.2019.00796","article-title":"Progestin vs. gonadotropin-releasing hormone antagonist for the prevention of premature luteinizing hormone surges in poor responders undergoing in vitro fertilization treatment: a randomized controlled trial","volume":"10","author":"Chen","year":"2019","journal-title":"Frontiers in Endocrinology"},{"issue":"7","key":"10.1002\/14651858.CD013827.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/1471-0528.14622","article-title":"The pregnancy outcome of progestin-primed ovarian stimulation using 4 versus 10 mg of medroxyprogesterone acetate per day in infertile women undergoing in vitro fertilisation: a randomised controlled trial","volume":"124","author":"Dong","year":"2017","journal-title":"BJOG: an International Journal of Obstetrics and Gynaecology"},{"issue":"1","key":"10.1002\/14651858.CD013827.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.18502\/ijrm.v18i1.6197","article-title":"Effect of oral Utrogestan in comparison with Cetrotide on preventing luteinizing hormone surge in IVF cycles: a randomized controlled trial","volume":"18","author":"Ghasemzadeh","year":"2019","journal-title":"International Journal of Reproductive BioMedicine"},{"issue":"2","key":"10.1002\/14651858.CD013827.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.fertnstert.2021.02.036","article-title":"Medroxyprogesterone acetate is a useful alternative to a gonadotropin-releasing hormone antagonist in oocyte donation: a randomized, controlled trial","volume":"16","author":"Giles","year":"2021","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD013827.pub2-BIB0009|cit9","unstructured":"Giles J Gamiz P Vidal C Badia P Bosch E Can serve Medroxiprogesterone acetate (MPA) as pituitary suppressor instead of GnRH antagonist during ovarian stimulation (OS) in oocyte donation (OD) cycles trigger with GnRH agonist? Human reproduction. Conference: 36th annual meeting of the european human reproduction and embryology. ESHRE. Virtual meeting 2020;35 Suppl 1():i5 2020"},{"key":"10.1002\/14651858.CD013827.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fendo.2020.00129","article-title":"Efficacy of different progestins in women with advanced endometriosis undergoing controlled ovarian hyperstimulation for in vitro fertilization-a single-center non-inferiority randomized controlled trial","volume":"11","author":"Guo","year":"2020","journal-title":"Frontiers in Endocrinology"},{"key":"10.1002\/14651858.CD013827.pub2-BIB0011|cit11","first-page":"i68","article-title":"Pituitary supression is not necessary for blocking LH surge during luteal-phase stimulation","volume":"35 Suppl 1","author":"Cruz Palomino","year":"2020","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD013827.pub2-BIB0012|cit12","first-page":"i301","article-title":"Outcome of progestin-primed ovarian stimulation protocol vs. ultra-long protocol in patients with a first IVF\/ICSI cycle: a randomized clinical trial","volume":"33 Suppl 1","author":"Qianwen","year":"2018","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD013827.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2147\/CLEP.S226414","article-title":"Comparison between ppos and gnrha-long protocol in clinical outcome with the first ivf\/ icsi cycle: a randomized clinical trial","volume":"12","author":"Xi","year":"2020","journal-title":"Clinical epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD013827.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/humrep\/dex367","article-title":"New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF\/ICSI cycles","volume":"33","author":"Yu","year":"2018","journal-title":"Human Reproduction"},{"issue":"37","key":"10.1002\/14651858.CD013827.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.fertnstert.2017.06.017","article-title":"Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization\/intracytoplasmic sperm injection treatments in combination with embryo cryopreservation","volume":"108","author":"Zhu","year":"2017","journal-title":"Fertility Sterility"},{"key":"10.1002\/14651858.CD013827.pub2-BIB0016|cit16","first-page":"i447","article-title":"The usage of Daphaston and hMG protocol in normalovulatory women undergoing controlled ovarian hyperstimulation during IVF\/ICSI treatments in combination with embryo cryopreservation","volume":"32 Suppl 1","author":"Zhu","year":"2017","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD013827.pub2-BIB0017|cit17","first-page":"i421","article-title":"The comparison of Utrogestan 100 mg or 200 mg per day used for controlled ovarian hyperstimulation in normalovulatory women: a prospective, randomized, controlled trial","volume":"31 Supp1","author":"Fu","year":"2016","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD013827.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.fertnstert.2016.10.030","article-title":"The use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection treatments in combination with a freeze all strategy: a randomized controlled dose-finding study of 100 mg versus 200 mg","volume":"107","author":"Zhu","year":"2017","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1002\/14651858.CD013827.pub2-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"387","DOI":"10.21037\/atm-20-1592","article-title":"Progesterone protocol versus gonadotropin-releasing hormone antagonist protocol in women with polycystic ovarian syndrome undergoing in vitro fertilization treatments with frozen-thawed embryo transfer: a prospective randomized controlled trial","volume":"9","author":"Zhu","year":"2021","journal-title":"Annals of Translational Medicine"},{"issue":"1","key":"10.1002\/14651858.CD013827.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12958-017-0291-0","article-title":"Controlled ovulation of the dominant follicle using progestin in minimal stimulation in poor responders","volume":"15","author":"Chen","year":"2017","journal-title":"Reproductive Biology and Endocrinology"},{"issue":"1","key":"10.1002\/14651858.CD013827.pub2-BIB0021|cit21","first-page":"14","article-title":"Comparison of Dydrogesterone and GnRH Antagonists for prevention of premature LH surge in IVF\/ICSI Cycles: ar andomized controlled trial","volume":"14","author":"Hossein Rashidi","journal-title":"Journal of family & Reproductive Health"},{"issue":"3","key":"10.1002\/14651858.CD013827.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00404-018-4856-8","article-title":"New trial of progestin-primed ovarian stimulation using dydrogesterone versus a typical GnRH antagonist regimen in assisted reproductive technology","volume":"298","year":"2018","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"1","key":"10.1002\/14651858.CD013827.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.fertnstert.2015.03.022","article-title":"Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization","volume":"104","author":"Kuang","year":"2015","journal-title":"Fertility and Sterility"},{"issue":"9","key":"10.1002\/14651858.CD013827.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"e2939","DOI":"10.1097\/MD.0000000000002939","article-title":"Controlled ovarian stimulation using medroxyprogesterone acetate and hmg in patients with polycystic ovary syndrome treated for ivf: a double-blind randomized crossover clinical trial","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine"},{"issue":"9","key":"10.1002\/14651858.CD013827.pub2-BIB0025|cit25","first-page":"671","article-title":"Progesterone-primed ovarian stimulation in polycystic ovarian syndrome: an RCT","volume":"17","author":"Eftekhar","year":"2019","journal-title":"International Journal of Reproductive BioMedicine"},{"key":"10.1002\/14651858.CD013827.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.12659\/MSM.906602","article-title":"Lipidomic components alterations of human follicular fluid reveal the relevance of improving clinical outcomes in women using progestin-primed ovarian stimulation compared to short-term protocol","volume":"24","author":"Wen","journal-title":"Medical Science Monitor"},{"issue":"12","key":"10.1002\/14651858.CD013827.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"e038153","DOI":"10.1136\/bmjopen-2020-038153","article-title":"Comparison of a progestin-primed ovarian stimulation protocol with a flexible GnRH antagonist protocol in patients with polycystic ovary syndrome who are participating in an IVF programme: study protocol for a randomised controlled trial","volume":"10","author":"Wang","journal-title":"BMJ Open"},{"issue":"1","key":"10.1002\/14651858.CD013827.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1186\/s13063-018-2850-x","article-title":"Gonadotropin-releasing hormone antagonist versus progestin for the prevention of premature luteinising hormone surges in poor responders undergoing in vitro fertilisation treatment: study protocol for a randomised controlled trial","volume":"19","author":"Wang","year":"2018","journal-title":"Trials"},{"key":"10.1002\/14651858.CD013827.pub2-BIB0029|cit29","unstructured":"Flexible progestin primed ovarian stimulation in patients with polycystic ovarian syndrome https:\/\/en.irct.ir\/trial\/55245"},{"key":"10.1002\/14651858.CD013827.pub2-BIB0030|cit30","unstructured":"Evaluation of oral Medroxyprogesterone acetate effect in the prevention of premature LH surge in IVF cycles in comparison with antagonist protocol https:\/\/en.irct.ir\/trial\/46951"},{"key":"10.1002\/14651858.CD013827.pub2-BIB0031|cit31","unstructured":"Comparison of progesterone effect in preventing LH surge and quality of oocytes and embryos in IVF cycles with patients undergoing antagonist cycle in Shariati Hospital during 1997-1998"},{"key":"10.1002\/14651858.CD013827.pub2-BIB0032|cit32","unstructured":"Comparison of the live birth rate between the PPOS and the GnRH Antagonist protocol in patients undergoing IVF"},{"key":"10.1002\/14651858.CD013827.pub2-BIB0033|cit33","unstructured":"New ovarian stimulation with random start, use of progestin protocol for oocyte donors (RANDOS)"},{"key":"10.1002\/14651858.CD013827.pub2-BIB0034|cit34","unstructured":"Live Birth Rate Between PPOS and GnRH Antagonist protocol in patients with anticipated high ovarian response"},{"key":"10.1002\/14651858.CD013827.pub2-BIB0035|cit35","unstructured":"The rate of embryo euploidy in women treated with progestin-primed ovarian stimulation versus conventional ovarian stimulation: a randomised controlled trial"},{"issue":"6","key":"10.1002\/14651858.CD013827.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.rbmo.2020.01.027","article-title":"Progestins versus GnRH analogues for pituitary suppression during ovarian stimulation for assisted reproductive technology: a systematic review and meta-analysis","volume":"40","author":"Alexandru","year":"2020","journal-title":"Reproductive BioMedicine Online"},{"issue":"1","key":"10.1002\/14651858.CD013827.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/humupd\/dmaa040","article-title":"Progestins for pituitary suppression during ovarian stimulation for ART: a comprehensive and systematic review including meta-analyses","volume":"27","author":"Ata","journal-title":"Human Reproduction Update"},{"issue":"5","key":"10.1002\/14651858.CD013827.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/humrep\/dez034","article-title":"Medroxyprogesterone acetate versus ganirelix in oocyte donation: a randomized controlled trial","volume":"34","author":"Beguer\u00eda","year":"2019","journal-title":"Human Reproduction"},{"issue":"7","key":"10.1002\/14651858.CD013827.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"102049","DOI":"10.1016\/j.jogoh.2020.102049","article-title":"A meta-analysis of the efficacy of progestin-primed ovarian stimulation with medroxyprogesterone acetate in ovulation induction in poor ovarian responders","volume":"50","author":"Cai","year":"2021","journal-title":"Journal of Gynecology Obstetrics and Human Reproduction"},{"issue":"4","key":"10.1002\/14651858.CD013827.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2147\/TCRM.S4192","article-title":"Luteal phase support in assisted reproductive technology treatment: focus on Endometrin\u00ae (progesterone) vaginal insert.","volume":"5","author":"Check","year":"2009","journal-title":"Therapeutics and Clinical Risk Management"},{"issue":"6","key":"10.1002\/14651858.CD013827.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa1513873","article-title":"Fresh versus frozen embryos for infertility in the polycystic ovary syndrome","volume":"375","author":"Chen","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD013827.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"615630","DOI":"10.1007\/s00404-020-05939-y","article-title":"Effectiveness of progesterone-primed ovarian stimulation in assisted reproductive technology: a systematic review and meta-analysis","volume":"303","author":"Cui","year":"2021","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"1","key":"10.1002\/14651858.CD013827.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1477-7827-10-26","article-title":"GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF\/ET)","volume":"10","author":"Depalo","year":"2012","journal-title":"Reproductive and Biological Endocrinology"},{"issue":"5","key":"10.1002\/14651858.CD013827.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0015-0282(98)00043-0","article-title":"Local side effects of subcutaneous and intramuscular urinary gonadotropins for ovarian stimulation in in vitro fertilization: a prospective, randomized study","volume":"69","author":"Engmann","year":"1998","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1002\/14651858.CD013827.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.fertnstert.2015.07.1139","article-title":"Disparities in access to effective treatment for infertility in the United States: an Ethics Committee opinion","volume":"104","author":"Ethics Committee of the American Society for Reproductive Medicine","year":"2015","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD013827.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/biolre\/ioy082","article-title":"Adverse effect of prematurely elevated progesterone in in vitro fertilization cycles: a literature review","volume":"99","author":"Evans","year":"2018","journal-title":"Biology of Reproduction"},{"issue":"5","key":"10.1002\/14651858.CD013827.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.rbmo.2018.12.044","article-title":"Evaluation of the cost-effectiveness of ovulation suppression with progestins compared with GnRH analogs in assisted reproduction cycles","volume":"38","author":"Evans","year":"2019","journal-title":"Reproductive Biomedicine Online"},{"issue":"4","key":"10.1002\/14651858.CD013827.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/humrep\/dex008","article-title":"Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients","volume":"32","author":"Goldman","year":"2017","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD013827.pub2-BIB0049|cit49","unstructured":"GRADEpro GDT 2015 McMaster University (developed by Evidence Prime) 2015"},{"key":"10.1002\/14651858.CD013827.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3389\/fendo.2021.702558","article-title":"Progestin-primed ovarian stimulation protocol for patients in assisted reproductive technology: a meta-analysis of randomized controlled trials","volume":"12","author":"Guan","year":"2021","journal-title":"Frontiers in Endocrinology"},{"key":"10.1002\/14651858.CD013827.pub2-BIB0051|cit51","volume-title":"Yen & Jaffe's Reproductive Endocrinology Physiology, Pathophysiology, and Clinical Management","author":"Hall","year":"2013"},{"key":"10.1002\/14651858.CD013827.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0010-7824(95)00255-3","article-title":"Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions","volume":"53","author":"Heikinheimo","year":"1996","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD013827.pub2-BIB0053|cit53","doi-asserted-by":"crossref","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019 Available from www.training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604"},{"key":"10.1002\/14651858.CD013827.pub2-BIB0054|cit54","unstructured":"Holesh JE Bass AN StatPearls [Internet] Treasure Island (FL) StatPearls Publishing"},{"issue":"4","key":"10.1002\/14651858.CD013827.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/humupd\/dmv016","article-title":"Infertility around the globe: new thinking on gender, reproductive technologies and global movements in the 21st century","volume":"21","author":"Inhorn","year":"2015","journal-title":"Human Reproduction Update"},{"issue":"1","key":"10.1002\/14651858.CD013827.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.fertnstert.2015.03.022","article-title":"Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization","volume":"104","author":"Kuang","year":"2015","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD013827.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.rbmo.2019.03.212","article-title":"Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era?","volume":"39","author":"Capuzzo","year":"2019","journal-title":"Reproductive Biomedicine Online"},{"key":"10.1002\/14651858.CD013827.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.2147\/DDDT.S263138","article-title":"Live-birth outcomes and congenital malformations after progestin-primed ovarian stimulation in maternal endometriosis","volume":"14","author":"Liang","year":"2020","journal-title":"Drug Design Development and Therapy"},{"key":"10.1002\/14651858.CD013827.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jri.2017.05.001","article-title":"The effect of elevated progesterone levels before oocyte retrieval in women undergoing ovarian stimulation for IVF treatment on the genomic profile of peri-implantation endometrium","volume":"121","author":"Liu","year":"2017","journal-title":"Journal of Reproductive Immunology"},{"issue":"4","key":"10.1002\/14651858.CD013827.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dmab008","article-title":"Ovarian stimulation for oocyte donation: a systematic review and meta-analysis","volume":"27","author":"Martinez","journal-title":"Human Reproduction Update"},{"issue":"2","key":"10.1002\/14651858.CD013827.pub2-BIB0061|cit61","first-page":"211","article-title":"New stimulation regimens: endogenous and exogenous progesterone use to block the LH surge during ovarian stimulation for IVF","volume":"23","author":"Massin","year":"2017","journal-title":"Human Reproduction Update"},{"issue":"1","key":"10.1002\/14651858.CD013827.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13048-020-00620-z","article-title":"Outcomes of fertility preservation in women with endometriosis: comparison of progestin-primed ovarian stimulation versus antagonist protocols","volume":"13","author":"Mathieu d\u2019Argent","year":"2020","journal-title":"Journal of Ovarian Research"},{"key":"10.1002\/14651858.CD013827.pub2-BIB0063|cit63","unstructured":"Review Manager Web (RevMan Web) The Cochrane Collaboration 2020"},{"issue":"2","key":"10.1002\/14651858.CD013827.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1056\/NEJMoa1705334","article-title":"Transfer of fresh versus frozen embryos in ovulatory women","volume":"378","author":"Shi","year":"2018","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD013827.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD013827.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.rbmo.2010.11.002","article-title":"Progesterone rise on HCG day in GnRH antagonist\/rFSH stimulated cycles affects endometrial gene expression","volume":"22","author":"Van Vaerenbergh","year":"2011","journal-title":"Reproductive Biomedicine Online"},{"issue":"2","key":"10.1002\/14651858.CD013827.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1056\/NEJMoa1703768","article-title":"IVF transfer of fresh or frozen embryos in women without polycystic ovaries","volume":"378","author":"Vuong","year":"2018","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD013827.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"e0175985","DOI":"10.1371\/journal.pone.0175985","article-title":"Comparisons of GnRH antagonist protocol versus GnRH agonist long protocol in patients with normal ovarian reserve: a systematic review and meta-analysis","volume":"12","author":"Wang","year":"2017","journal-title":"PLOS One"},{"issue":"10178","key":"10.1002\/14651858.CD013827.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/S0140-6736(18)32843-5","article-title":"Frozen versus fresh single blastocyst transfer in ovulatory women: a multicentre, randomised controlled trial","volume":"393","author":"Wei","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD013827.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/humrep\/dex367","article-title":"New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF\/ICSI cycles","volume":"33","author":"Yu","year":"2018","journal-title":"Human Reproduction"},{"issue":"6","key":"10.1002\/14651858.CD013827.pub2-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1007\/s00404-017-4537-z","article-title":"Neonatal outcomes and congenital malformations in children born after human menopausal gonadotropin and medroxyprogesterone acetate treatment cycles","volume":"296","author":"Zhang","year":"2017","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"12","key":"10.1002\/14651858.CD013827.pub2-BIB0072|cit72","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013827","article-title":"Progestogens for prevention of luteinising hormone (LH) surge in women undergoing controlled ovarian hyperstimulation as part of an assisted reproductive technology (ART) cycle","author":"Glujovsky","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T20:06:41Z","timestamp":1750018001000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013827.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecology and Fertility Group","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,11,30]]},"references-count":72,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013827.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,30]]}}}